当前位置: 首页 > 期刊 > 《上海医药》 > 2018年第19期
编号:13291141
胆囊癌外科治疗理念变迁(3)
http://www.100md.com 2018年7月5日 《上海医药》 2018年第19期
     [8] 刘颖斌, 吴向嵩, 李茂岚, 等. 胆囊癌外科治疗的热点与争议[J]. 中华消化外科杂志, 2018, 17(3): 225-228.

    [9] Kishi Y, Nara S, Esaki M, et al. Extent of lymph node dissection in patients with gallbladder cancer [J/OL]. Br J Surg, 2018 Jul 11 [2018-08-25]. doi: 10.1002/bjs.10913.

    [10] Piccolo G, Di Vita M, Cavallaro A, et al. Lymph node evaluation in gallbladder cancer: which role in the prognostic and therapeutic aspects. Update of the literature [J]. Eur Rev Med Pharmacol Sci, 2014, 18(2 Suppl): 47-53.

    [11] Fan DX, Xu RW, Li YC, et al. Impact of the number of examined lymph nodes on outcomes in patients with lymph node-negative gallbladder carcinoma [J]. World J Gastroenterol, 2018, 24(26): 2886-2892.

    [12] D’Hondt M, Lapointe R, Benamira Z, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience [J]. Eur J Surg Oncol, 2013, 39(6): 548-553.

    [13] Shirai Y, Sakata J, Wakai T, et al. “Extended” radical cholecystectomy for gallbladder cancer: long-term outcomes, indications and limitations [J]. World J Gastroenterol, 2012, 18(34): 4736-4743.

    [14] Sternby Eilard M, Lundgren L, Cahlin C, et al. Surgical treatment for gallbladder cancer — a systematic literature review [J]. Scand J Gastroenterol, 2017, 52(5): 505-514.

    [15] 劉颖斌, 吴文广, 全志伟. 胆囊癌的靶向治疗[J]. 中华实用外科杂志, 2010, 30(7): 553-555., http://www.100md.com(李茂岚 赵铭宁 刘颖斌)
上一页1 2 3